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Abstract 
Avian intestinal spirochaetosis (AIS) is a disease complex affecting adult laying and breeding 
chickens associated with infection by anaerobic intestinal spirochaetes of the genus Brachyspira. 
Options for control of AIS are limited, as few effective antimicrobial agents are registered for use in 
laying chickens. One of the two most commonly encountered pathogenic species in AIS is B. 
intermedia, and the aim of the current study was to determine whether a B. intermedia bacterin 
vaccine would help control AIS caused by this species. An autogenous bacterin was prepared from B. 
intermedia strain HB60 and given twice intramuscularly at a 3-week interval to 12 laying chickens 
housed in individual cages. Twelve non-vaccinated control chickens were placed in adjacent cages in 
the same room. Two weeks after the second vaccination all the chickens were experimentally 
challenged with B. intermedia HB60 by crop tube. Subsequently faeces were cultured for spirochaetes 
every 2–3 days, faecal water content and chicken weight were measured weekly, and egg numbers 
and weights were recorded daily. Serum was taken prior to both vaccinations, at the time of challenge 
and at euthanasia. The chickens were killed 6 weeks post-challenge. The vaccinated chickens showed 
seroconversion to the vaccine, but antibody levels declined significantly post-infection. In 
comparison, the non-vaccinated chickens showed seroconversion post-infection. The reason for the 
reduction in the antibody levels in the vaccinated chickens after infection was not explained. At some 
point all the chickens excreted spirochaetes in their faeces, and the duration of excretion was not 
different between vaccinated and non-vaccinated chickens. There were no differences in faecal water 
content, chicken weights, egg production, or gross and microscopic caecal lesions between vaccinated 
and non-vaccinated chickens. In conclusion, an autogenous bacterin vaccine did not prevent infection 
with B. intermedia in laying chickens. 
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Introduction 
Avian intestinal spirochaetosis (AIS) is a disease complex associated with colonization of adult 
chickens or other poultry species by pathogenic intestinal spirochaetes of the genus Brachyspira 
(formerly Serpulina) ( Swayne and McLaren, 1997, Stephens and Hampson, 2001 and Hampson and 
Swayne, 2008). AIS most commonly has been reported in flocks of laying hens and broiler breeders 
where it has been associated with a variety of non-specific clinical signs and production problems. 
Reported examples of problems include pasty vents, wet litter, faecal staining of eggshells, increased 
fat content of faeces, delayed onset of egg laying, reduced egg production, increased mortalities, and a 
reduced feed conversion ratio ( Devalaar et al., 1986, Griffiths et al., 1987, Dwars et al., 1989, 
Swayne et al., 1992, Swayne et al., 1995, Trampel et al., 1994, Hampson and McLaren, 1999, 
Stephens and Hampson, 2001, Burch et al., 2006 and Bano et al., 2008). Broiler flocks derived from 
infected breeders may show poor feed conversion ratios, a high number of weak chicks, slow growth, 
and poor feed digestion ( Dwars et al., 1993 and Smith et al., 1998). 
Infections with the pathogenic species B. intermedia, B. pilosicoli, B. alvinipulli, and B. 
hyodysenteriae have all been reported in chickens, with B. intermedia usually being most consistently 
and commonly encountered in epidemiological surveys of flocks with AIS ( McLaren et al., 1997, 
Stephens and Hampson, 1999, Stephens et al., 2005, Bano et al., 2008, Feberwee et al., 
2008 and Jansson et al., 2008). 
 
Infections with Brachyspira species in pigs are routinely controlled using antimicrobial agents, but 
there are few antimicrobials available that are registered for use in laying chickens, and this makes 
control of AIS difficult. Implementing good shed hygiene and strict biosecurity measures can be used 
to try to prevent infection being introduced into flocks (Phillips et al., 2003), but this strategy is not 
always successful. To date there are no commercial vaccines available to help prevent or control AIS. 
 
The aim of the current work was to undertake a pilot study to determine whether vaccination with an 
autogenous bacterin could confer protection against AIS caused by B. intermedia in laying chickens. 
 
Materials and methods 
Permissions 
The experimental work was conducted with the approval of the Murdoch University Animals Ethics 
Committee. 
 
Spirochaete growth 
B. intermedia strain HB60, originally isolated from a chicken in a Western Australian layer flock with 
a wet litter problem, was obtained as frozen stock from the culture collection held at the Australian 
Reference Centre for Intestine Spirochaetes, School of Veterinary and Biomedical Sciences, Murdoch 
University. The cells were thawed, and grown at 37 °C in Kunkle's pre-reduced anaerobic broth 
containing 2% (v/v) foetal bovine serum and 1% (v/v) ethanolic cholesterol solution (Kunkle et al., 
1986). The spirochaetes were harvested in early log-phase, when they were actively motile. 
Spirochaete growth and absence of contamination were monitored by examining aliquots under a 
phase contrast microscope. 
 
Bacterin vaccine 
The spirochaete cells were harvested by centrifugation, washed three times in sterile phosphate 
buffered saline (PBS), pH 7.2, resuspended in PBS and inactivated by addition of 0.4% formalin 
followed by stirring overnight at 4 °C. The spirochaetes were counted in a haemocytometer chamber 
under a phase contrast microscope, adjusted to 1010 cells/ml, aliquoted and stored at −20 °C. 
Immediately before administration the bacterin was thawed and sonicated in a commercial water-in-
oil adjuvant (Emulsigen; MUP Laboratories Inc., Ralston, USA) to produce an emulsion. 
 
Serum samples 
The chickens were bled from the marginal wing vein four times during the course of the experiment, 
commencing immediately prior to the first vaccination (pre-vaccination), immediately prior to the 
second vaccination (pre-boost), immediately prior to the experimental challenge (pre-infection) and at 
post-mortem. The blood was held at 4 °C overnight and the serum was removed, divided into aliquots 
and stored at −20 °C. Immediately prior to use the sera were thawed on ice and briefly vortexed. 
 
 
 
ELISA 
Whole cells of B. intermedia HB60 (108 ml−1 in PBS) were sonicated on ice using three cycles of 30 s 
with 2 min between cycles. The sonicate was centrifuged at 10,000 × g for 10 min and the supernatant 
used as plate coating antigen stock. Total protein content was determined using a commercial dye-
binding assay kit (Bio-Rad Laboratories, Hercules, CA, USA), then the sonicate was diluted in 
bicarbonate/carbonate coating buffer (pH 9.6) to a working dilution of 2 μg total protein/ml. 100 μl of 
the working dilution was added to each well of a 96-well microtitre plate (Becton Dickinson, Lincoln 
Park, NJ, USA) and the plate was left at 4 °C overnight. The coating solution was poured off and each 
well was blocked for 1 h at 25 °C with 150 μl of PBS containing 1% (w/v) bovine albumin, fraction V 
(Sigma, St Louis, MO, USA; Cat. No. A3803). The blocking solution was poured off and the plate 
was washed three times in PBS–0.05% (v/v) Tween 20 (PBST). A single serum dilution ELISA was 
used, as dilutions in the range 100–500 give a linear response (T. La and D.J. Hampson, unpublished 
data). Each serum sample was diluted 1:100 in PBST containing 0.1% (w/v) bovine albumin, fraction 
V, and 100 μl was added to each well. Plates were incubated at 25 °C for 2 h with gentle shaking, then 
washed three times with PBST. 100 μl of diluted (1:20,000) goat anti-chicken IgG (whole molecule) 
horseradish peroxidase conjugate (Sigma–Aldrich, Castle Hill, Australia) was added to each well and 
the plates incubated at 25 °C for 1 h with gentle shaking. The plates were washed three times with 
PBST and 100 μl of 1-Step™ Turbo TMB-ELISA (Thermo Scientific, Rockford, IL, USA) substrate 
solution was added to each well and incubated for 10 min at 25 °C. Colour development was stopped 
with 100 μl of 1 M H2SO4 before reading the absorbance in an ELISA plate reader at 450 nm. Mean 
absorbance values were plotted for the chickens in each group. 
 
Spirochaete isolation and PCR 
Bacteriology swabs were used to collect discrete samples of fresh faeces from the cage floor of each 
chicken, and also to swab the mucosal surface of the caecal walls and rectum at post-mortem. The 
swabs were used to inoculate selective agar plates (Jenkinson and Wingar, 1981), consisting of 
Trypticase Soy agar (BBL, Cockeysville, USA) containing 5% (v/v) defibrinated sheep blood, 
400 μg/ml spectinomycin and 25 μg/ml each of colistin and vancomycin (Sigma–Aldrich). The plates 
were incubated for 5–7 days at 37 °C in a jar with an anaerobic environment generated using a 
GasPak Plus™ disposable hydrogen plus carbon dioxide generator envelope with a palladium catalyst 
(Becton Dickinson Microbiology Systems). The presence of low flat spreading growth of spirochaetes 
on the plate was recorded. The suspected areas of spirochaete growth were resuspended in PBS, and 
examined under a phase contrast microscope at 400× magnification. Spirochaetal growth was 
collected from the surface of the plate using a wooden toothpick, resuspended in ultra-pure water and 
used as a template for B. intermedia PCR amplification, as previously described (Phillips et al., 2005). 
 
Experimental protocol 
Twenty-four ISA-Brown laying chickens of 20 weeks of age were purchased from a commercial 
breeder and housed in individual cages with mesh floors located in a room in an environmentally 
controlled (22–25 °C) facility. The chickens were subjected to 12 h artificial light each day. They 
were fed ad libitum on a commercial mash formulated to meet the nutritional requirements of laying 
chickens, and water was available to them ad libitum. Twelve of the chickens were vaccinated with 
the bacterin and the other 12 chickens were left unvaccinated. The cages were arranged so that each 
alternate cage contained a vaccinated chicken. 
 
One week after arrival, at 21 weeks of age, the chickens were vaccinated with 1 ml of the bacterin 
vaccine by injection into the pectoral muscles. They were vaccinated again 3 weeks later, at 24 weeks 
of age. 
 
The chickens were weighed on entry to the experiment and at weekly intervals thereafter. Eggs were 
collected daily and weighed. At weekly intervals aluminum foil was placed under the cage of each 
chicken, and after 1-h individual caecal faeces samples were collected. Approximately 2 g of the 
samples were weighed, and then dried to constant weight in a hot air oven to determine their moisture 
content. 
 
Faeces were collected from all chickens prior to experimental infection, and then every 2–3 days until 
the end of the experiment. For each subgroup a total of 180 excreta samples were obtained at 15 
sampling times over the 5-week post-infection period. 
 
Experimental infection 
Experimental infection commenced 2 weeks after the second vaccination, when the chickens were 26 
weeks of age, and all were laying eggs. The chickens were orally inoculated via a crop tube with 4 ml 
of the appropriate actively growing culture, on 4 consecutive days. The broths contained 
approximately 108 to 109 motile bacterial cells/ml. 
 
Post-mortem examination 
Six weeks after the experimental challenge (at 32 weeks of age) the chickens were killed by cervical 
dislocation, and subjected to post-mortem examination. The caecum and rectum were opened to look 
for evidence of gross changes. A section of one caecum was placed in 10% neutral buffered formalin 
as a fixative for subsequent histological examination, and swabs were taken from the wall of the other 
caecum and the rectum for spirochaete culture. These were processed as for faecal samples. The fixed 
tissue was processed through to paraffin blocks, sectioned at 4 μm and stained with haematoxylin and 
eosin and with the Warthin–Starry silver stain. 
 
 
Analysis of data 
Comparisons were made between the two groups of chickens using InStat version 3 (Graphpad 
Software, San Diego, CA, USA). The ratio of the total number of faecal samples collected that were 
positive and negative for B. intermedia were compared between the vaccinated and non-vaccinated 
groups using Chi-squared tests. Weekly weights, faecal moisture content, egg numbers, and egg 
weights were compared using one-way analysis of variance. Means were compared using the Tukey–
Kramer multiple comparisons test, with significance accepted at the 5% level. 
 
Results 
Antibody levels 
Vaccinated chickens showed a significant (P < 0.05) primary antibody response following the first 
vaccination (Fig. 1). The mean antibody level increased following the second vaccination, but this 
increase just failed to reach statistical significance. The antibody level then showed a significant 
(P < 0.01) reduction at post-mortem, with 10 of the 12 vaccinated chickens showing reductions in 
antibody levels. In comparison, the non-vaccinated chickens only showed a significant (P < 0.001) 
increase in antibody levels following experimental infection. 
 
Colonization 
None of the chickens were positive for intestinal spirochaetes prior to experimental infection. 
Following experimental challenge, all chickens excreted spirochaetes in their faeces at some point 
(range 1–13 samplings positive). Of the 180 faecal samples that were collected over the post-infection 
period, 82 (45.6.%) were B. intermedia positive for the vaccinated chickens and 80 (44.4%) were 
positive for the unvaccinated chickens. These differences were not statistically significant. At post-
mortem B. intermedia was isolated from the caecum and/or rectum of 8 vaccinated chickens and from 
11 of the non-vaccinated chickens. Again these differences were not significant. 
 
Faecal water content 
Within each group the faecal water content of the chickens did not change significantly with time 
(Table 1), and pair-wise comparisons between the vaccinated and non-vaccinated chickens were not 
significantly different at any sampling time. 
 
Chicken weights, egg numbers, and egg weights 
No significant differences were found between the vaccinated and non-vaccinated chickens in weekly 
body weights, weekly egg weights, or weekly egg numbers (data not shown). 
 
Post-mortem findings 
At post-mortem chickens from both groups had enlarged ballooning caeca with frothy and mucoid 
contents. No gross pathological lesions were observed. Histologically all sections showed variable 
oedema and congestion of the lamina propria, and some sections showed localized areas of separation 
of the epithelium from the underlying lamina. Bacteria with the appearance of spirochaetes were seen 
in the crypts and adjacent to the luminal epithelium in all sections, with spirochaete-like forms seen in 
the lamina propria just under the epithelium in occasional sections. There were no consistent 
differences between the two groups of chickens in the appearances of the sections or in the number or 
disposition of the spirochaete-like bacteria that were observed. 
 
 
Discussion 
B. intermedia strain HB60 previously has been used to experimentally infect laying chickens ( 
Hampson and McLaren, 1999, Hampson et al., 2002 and Phillips et al., 2004). In the current study this 
strain colonized the chickens, and the control chickens developed antibodies to whole cell extracts of 
the B. intermedia strain following experimental challenge. Unlike previous studies, the colonization 
was not associated with any obvious clinical signs such as reduced egg production and increased 
faecal water content, although there were abnormalities of the caecal contents and microscopic 
changes in the caeca. Whilst vaccination did result in elevated serum antibody levels to HB60, there 
was no evidence that this influenced colonization or reduced the mild pathological changes found in 
the caeca following experimental infection. Hence it appears that bacterin vaccines are unlikely to be 
particularly useful in preventing AIS caused by B. intermedia. 
 
Previously, bacterin vaccines against B. hyodysenteriae have been reported to offer variable and 
generally incomplete protection against swine dysentery in pigs ( Fernie et al., 1983, Hampson et al., 
1993, Diego et al., 1995 and Waters et al., 1999), whilst a bacterin against B. pilosicoli did not prevent 
colonization with this spirochaete in experimentally infected pigs (Hampson et al., 2000). Hence the 
failure of the current bacterin to offer protection in laying chickens is not altogether surprising. More 
recently the use of a swine dysentery vaccine based on a recombinant 29.7 kDa outer membrane 
lipoprotein (Bhlp29.7) of B. hyodysenteriae did provide a degree of protection to experimentally 
infected pigs (La et al., 2004). Hence it may be worth investigating similar outer membrane proteins 
and lipoproteins in B. intermedia to see if they could be used as the basis for a vaccine against B. 
intermedia in chickens. A mucosal route of delivery might also improve protection against 
colonization and lesion development in the caeca. 
 
An unexpected observation in the current experiment was the significant reduction in antibody levels 
in the vaccinated chickens following experimental infection. It appeared that the serum antibody 
generated by vaccination was removed from the circulation during the period following infection. 
Furthermore, despite the spirochaete colonizing the large intestine, there was no evidence of this 
boosting circulating antibody levels in the vaccinated chickens. These findings suggest the possibility 
that some form of immunological tolerance to B. intermedia developed as a result of vaccination. 
Although the control chickens did not receive the vaccine adjuvant, it seems unlikely that it would 
have been responsible for these results. Overall the current observations need further investigation, 
and should be taken into consideration when developing vaccines against B. intermedia in chickens. 
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Fig. 1. Mean and S.D. of serum ELISA absorbance values against whole cell preparations of B. intermedia 
strain HB60 in vaccinated and non-vaccinated laying chickens at four time points during the experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Mean (and S.D.) percent faecal water content in vaccinated and non-vaccinated chickens pre-challenge 
and in weeks 1–5 post-challenge with B. intermedia strain HB60 
 
 
 
 Pre-infection 
Weeks post-infection 
 
P-value 
  1 2 3 4 5  
Vaccinated 77.3 (9.0) 81.0 (1.8) 80.3 (3.2) 78.0 (7.0) 78.3 (2.3) 78.3 (6.4) 0.48 
Non-vaccinated 75.4 (13.0) 76.4 (4.1) 77.1 (7.9) 73.9 (16.9) 77.6 (4.4) 75.4 (6.4) 0.95 
 
 
 
 
